This is an archive of papers published by the staff and faculty of Fox Chase Cancer Center. For questions about content, please contact Talbot Research Library
Last updated on
Kantidze OL , Gurova KV , Studitsky VM , Razin SV
The 3D Genome as a Target for Anticancer Therapy
Trends Mol Med. 2020 Feb;26(2) :141-149
PMID: 31679987 URL: https://www.ncbi.nlm.nih.gov/pubmed/31679987
AbstractThe role of 3D genome organization in the precise regulation of gene expression is well established. Accordingly, the mechanistic connections between 3D genome alterations and disease development are becoming increasingly apparent. This opinion article provides a snapshot of our current understanding of the 3D genome alterations associated with cancers. We discuss potential connections of the 3D genome and cancer transcriptional addiction phenomenon as well as molecular mechanisms of action of 3D genome-disrupting drugs. Finally, we highlight issues and perspectives raised by the discovery of the first pharmaceutical strongly affecting 3D genome organization.
Notes1471-499x Kantidze, Omar L Gurova, Katerina V Studitsky, Vasily M Razin, Sergey V Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review England Trends Mol Med. 2020 Feb;26(2):141-149. doi: 10.1016/j.molmed.2019.09.011. Epub 2019 Oct 31.